1-4 of 4
David Haylock
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A thrombopoietin receptor antagonist is capable of depleting myelofibrosis hematopoietic stem and progenitor cells

Xiaoli Wang, David Haylock, Cing Siang Hu, Wioleta Kowalczyk, Tianbo Jiang, Jiajing Qiu, Goar Mosoyan, Wu He, Netonia Marshall, John Mascarenhas, Anna Tarasova, Joshua Brody, David Winkler, Ronald Hoffman
Journal: Blood
Blood (2016) 127 (26): 3398–3409.
https://doi.org/10.1182/blood-2015-10-674465
Published: 2016
Includes: Supplemental data
Journal Articles

A Thrombopoietin Antagonist Is Capable of Affecting Stem and Progenitor Cells of Patients with Myelofibrosis

Xiaoli Wang, David Haylock, Cing Siang Hu, Goar Mosoyan, Dave Winkler, Ronald Hoffman, MD
Journal: Blood
Blood (2014) 124 (21): 819.
https://doi.org/10.1182/blood.V124.21.819.819
Published: 2014
Journal Articles

The relationship between bone, hemopoietic stem cells, and vasculature

Sarah L. Ellis, Jochen Grassinger, Allan Jones, Judy Borg, Todd Camenisch, David Haylock, Ivan Bertoncello, Susan K. Nilsson
Journal: Blood
Blood (2011) 118 (6): 1516–1524.
https://doi.org/10.1182/blood-2010-08-303800
Published: 2011
Includes: Supplemental data
Journal Articles

Expression Profiling of a Hemopoietic Cell Survival Transcriptome Identifies a Functional Prognostic Gene Signature in Normal Karyotype AML.

Mark Guthridge, Daniel Thomas, MD, Emma F Barry, Kok H Chung, Barbara J McClure, L. Bik To, MD, Greg Goodall, Terry P Speed, Motomi Osato, David Haylock, Susie Nilsson, MD, Richard D'Andrea, PhD, Angel Lopez, Jason A Powell, PhD
Journal: Blood
Blood (2009) 114 (22): 1618.
https://doi.org/10.1182/blood.V114.22.1618.1618
Published: 2009